Nanomedicina

A nanotechnológia alkalmazása az orvostudományban. Leheto{double acute}ségek a neuropszichiátria területén

Research output: Article

9 Citations (Scopus)

Abstract

One of the most popular, most intensely expanding borderline of science and technology today is nanomedicine, the utilization of nanotechnology in medicine. The long lists of innovative medicinal and other products, astonishing market and scientometric indicators and the broad scale of promising therapeutic and diagnostic opportunities support the view that nanomedicine heralds the future of medicine. The goals of this review are to provide a comprehensive overview of the field, to compile the nanomedicines and other medical products that are on the market, and to address in more detail the most successful trend, targeted pharmacotherapy. Various nanocarriers (liposomes, micelles, polymer-conjugates, polymerosomes, dendrimers, aptamers and carbon nanotubes) will be presented, along with their targeting ligands, with special emphasis on liposomal doxorubicin (Doxil), the proto-type of long-circulating, targeted chemotherapeutic nanomedicine. Nanotechnology holds great promises for the field of neuropsychiatric pharmacotherapy as well, mainly through the introduction of pharmaceutical agents passing the blood-brain barrier. The review presents some of the approaches and examples of these attempts.

Original languageHungarian
Pages (from-to)15-24
Number of pages10
JournalNeuropsychopharmacologia Hungarica
Volume13
Issue number1
Publication statusPublished - márc. 2011

Fingerprint

Neuropsychiatry
Nanomedicine
Nanotechnology
Medicine
Dendrimers
Drug Therapy
Carbon Nanotubes
Micelles
Blood-Brain Barrier
Liposomes
Polymers
Ligands
Technology
Pharmaceutical Preparations
liposomal doxorubicin

Keywords

  • Blood-brain barrier
  • Liposomes
  • Nanocarriers
  • Nanotherapy
  • Neuropsychopharmacons
  • Targeted pharmacotherapy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Neuropsychology and Physiological Psychology
  • Clinical Neurology

Cite this

@article{7b3a1537946847c9bc573463f47cb2d6,
title = "Nanomedicina: A nanotechnol{\'o}gia alkalmaz{\'a}sa az orvostudom{\'a}nyban. Leheto{double acute}s{\'e}gek a neuropszichi{\'a}tria ter{\"u}let{\'e}n",
abstract = "One of the most popular, most intensely expanding borderline of science and technology today is nanomedicine, the utilization of nanotechnology in medicine. The long lists of innovative medicinal and other products, astonishing market and scientometric indicators and the broad scale of promising therapeutic and diagnostic opportunities support the view that nanomedicine heralds the future of medicine. The goals of this review are to provide a comprehensive overview of the field, to compile the nanomedicines and other medical products that are on the market, and to address in more detail the most successful trend, targeted pharmacotherapy. Various nanocarriers (liposomes, micelles, polymer-conjugates, polymerosomes, dendrimers, aptamers and carbon nanotubes) will be presented, along with their targeting ligands, with special emphasis on liposomal doxorubicin (Doxil), the proto-type of long-circulating, targeted chemotherapeutic nanomedicine. Nanotechnology holds great promises for the field of neuropsychiatric pharmacotherapy as well, mainly through the introduction of pharmaceutical agents passing the blood-brain barrier. The review presents some of the approaches and examples of these attempts.",
keywords = "Blood-brain barrier, Liposomes, Nanocarriers, Nanotherapy, Neuropsychopharmacons, Targeted pharmacotherapy",
author = "J. Szebeni",
year = "2011",
month = "3",
language = "Hungarian",
volume = "13",
pages = "15--24",
journal = "Neuropsychopharmacologia Hungarica",
issn = "1419-8711",
publisher = "Hungarian Association of Psychopharmacology",
number = "1",

}

TY - JOUR

T1 - Nanomedicina

T2 - A nanotechnológia alkalmazása az orvostudományban. Leheto{double acute}ségek a neuropszichiátria területén

AU - Szebeni, J.

PY - 2011/3

Y1 - 2011/3

N2 - One of the most popular, most intensely expanding borderline of science and technology today is nanomedicine, the utilization of nanotechnology in medicine. The long lists of innovative medicinal and other products, astonishing market and scientometric indicators and the broad scale of promising therapeutic and diagnostic opportunities support the view that nanomedicine heralds the future of medicine. The goals of this review are to provide a comprehensive overview of the field, to compile the nanomedicines and other medical products that are on the market, and to address in more detail the most successful trend, targeted pharmacotherapy. Various nanocarriers (liposomes, micelles, polymer-conjugates, polymerosomes, dendrimers, aptamers and carbon nanotubes) will be presented, along with their targeting ligands, with special emphasis on liposomal doxorubicin (Doxil), the proto-type of long-circulating, targeted chemotherapeutic nanomedicine. Nanotechnology holds great promises for the field of neuropsychiatric pharmacotherapy as well, mainly through the introduction of pharmaceutical agents passing the blood-brain barrier. The review presents some of the approaches and examples of these attempts.

AB - One of the most popular, most intensely expanding borderline of science and technology today is nanomedicine, the utilization of nanotechnology in medicine. The long lists of innovative medicinal and other products, astonishing market and scientometric indicators and the broad scale of promising therapeutic and diagnostic opportunities support the view that nanomedicine heralds the future of medicine. The goals of this review are to provide a comprehensive overview of the field, to compile the nanomedicines and other medical products that are on the market, and to address in more detail the most successful trend, targeted pharmacotherapy. Various nanocarriers (liposomes, micelles, polymer-conjugates, polymerosomes, dendrimers, aptamers and carbon nanotubes) will be presented, along with their targeting ligands, with special emphasis on liposomal doxorubicin (Doxil), the proto-type of long-circulating, targeted chemotherapeutic nanomedicine. Nanotechnology holds great promises for the field of neuropsychiatric pharmacotherapy as well, mainly through the introduction of pharmaceutical agents passing the blood-brain barrier. The review presents some of the approaches and examples of these attempts.

KW - Blood-brain barrier

KW - Liposomes

KW - Nanocarriers

KW - Nanotherapy

KW - Neuropsychopharmacons

KW - Targeted pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=79955812889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955812889&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 15

EP - 24

JO - Neuropsychopharmacologia Hungarica

JF - Neuropsychopharmacologia Hungarica

SN - 1419-8711

IS - 1

ER -